Eduardo Schenberg, Christine Hauskeller, Claudia Gertraud Schwarz, and Franklin King IV, Nature Mental Health When critically examining the assertion that biomedical treatments work for the ‘right’ reasons compared with alternative approaches, philosopher of science Isabelle Stengers1 coined the phrase ‘healing for the wrong reasons’. Here, we discuss the cognitive dissonances and regulatory misalignments apparent in the…
State Drug Laws
Mason Marks, Fordham Law Review This Essay provides a typology of state drug laws comprising thirteen categories, including decriminalization, recriminalization, adult use, supported adult use, medical use, supported medical use, religious use, social consumption, safe consumption, clinical research, policy analysis, trigger laws, and food and agricultural laws. Several states have enacted hybrid legislation that blends…
Momentum is Not Enough: A Call for Consistency in Psychedelic Legislation
Bill of Health // Petrie-Flom Center By Karina Bashir….
FDA rejects ecstasy as a therapy: what’s next for psychedelics?
Nature // Petrie-Flom Center Following the US drug agency’s decision, Nature examines the outlook for other hallucinogens that are in clinical trials as psychiatric treatments. By Sara Reardon, featuring I. Glenn Cohen and Mason Marks….
FDA rejected MDMA-assisted PTSD therapy. Other psychedelics firms intend to avoid that fate
Science // Petrie-Flom Center Lykos Therapeutics’s failure to win approval may trigger a strategic shift in psychedelic medicine. By Kai Kupferschmidt, featuring I. Glenn Cohen….
Getting to ‘Plan B’ for psychedelic medicine: Lessons from reproductive health
STAT // Petrie-Flom Center The Food and Drug Administration’s decision not to approve Lykos Therapeutics’ application for MDMA (a psychedelic drug known on the street as ecstasy or molly) plus therapy for post-traumatic stress disorder comes as no surprise, given an advisory panel’s “no” vote on the application in June. But if lessons from reproductive…
Psychedelic Therapy Scrutinized by FDA Advisory Committee?
Mason Marks, JAMA Network…
Psychedelics for Healing
Harvard Magazine // Petrie-Flom Center Harvard’s I. Glenn Cohen on the use of “magic mushrooms” and other psychedelics in medicine, by Olivia Farrar….
Mushroom edibles are rising in popularity. It’s hard to say what’s in them.
NBC News // Petrie-Flom Center A booming unregulated market is creating risks for consumers, who may not know what they’re getting. By Akshay Syal, featuring Mason Marks….
Mushroom Edibles Recalled After Spate of Serious Illnesses
The New York Times // Petrie-Flom Center At least 48 people have fallen ill after eating Diamond Shruumz products. The F.D.A. said it had found the brand’s products contained toxic levels of a psychoactive chemical. By Dani Blum, featuring Mason Marks….